Talisman Metals (TLM) Share Price, News & Analysis

Company Overview

Talisman Metals is committed to the exploration and development of multiple copper deposits across its Tizert and Argana projects, located in Morocco. Leveraging both advanced geological analysis and the latest exploration technologies, the company's expert team is dedicated to unlocking the region's vast mineral potential. With a focus on sustainability and innovation, Talisman aims to bring new, high-quality sources of copper to meet growing global demand and support the transition to a greener, electrified future.

Key Stats

• Today's Range: 7 to 8
• 50-Day Range: 7 to 10.65
• 52-Week Range: 7 to 14
• Volume: 189,467 shs
• Average Volume: 201,879 shs
• Market Capitalization: £4.49 million
• P/E Ratio: N/A
• Dividend Yield: 0.83%
• Price Target: N/A
• Consensus Rating: N/A

TLM Stock Analysis - Frequently Asked Questions

How have TLM shares performed this year?

Talisman Metals' stock was trading at GBX 3.45 at the start of the year. Since then, TLM stock has increased by 102.9% and is now trading at GBX 7.

When did Talisman Metals' stock split?

Shares of Talisman Metals reverse split on Wednesday, January 28th 2026.The 1-3 reverse split was announced on Wednesday, January 28th 2026. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 28th 2026. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

How do I buy shares of Talisman Metals?

Shares of TLM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:TLM
• Previous Symbol: LON:OVB
• CIK: N/A
• Web: www.ovocabio.com
• Phone: 353 1 661 9819
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX (1.32)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -£1.35 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -32.71%
• Return on Assets: 3.70%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.47
• Quick Ratio: 1.77

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: GBX 7.03 per share
• Price / Cash Flow: 1.00
• Book Value: GBX 2.41 per share
• Price / Book: 2.90

Miscellaneous

• Outstanding Shares: 64,175,000
• Free Float: N/A
• Market Cap: £4.49 million
• Optionable: Not Optionable
• Beta: 0.90